Massachusetts-based cannabis company Curaleaf Holdings Inc.
said Wednesday it was buying multi-state operator GR Companies Inc. in a deal valued at $875 million in cash and stock. Under terms of the deal, Curaleaf will pay $75 million in cash and provide 102.8 million subordinate voting shares and $40 million worth of shares. The acquisition, which is expected to close in early 2020, will increase Curaleaf's presence to 19 states from 12, including Illinois, which legalized adult-use cannabis in June.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:
United States United States Latest News, United States United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
'Google is not a patriotic company,' says co-founder of data-mining company PalantirJoe Lonsdale says his fellow Palantir co-founder Peter Thiel was 'courageous' for speaking out against Alphabet's Google. 'Companies' aren't ever patriotic. If someone is claiming their company is, they're lying. Just the thought is idiotic. Palantir is not patriotic either, no for profit is or should be, but it also should not abuse the laws and ethics But is it a fraudulent company? Because they do sell this 💩 to investors as ownership instruments.
Source: CNBC - 🏆 12. / 72 Read more »
Jay-Z named chief brand strategist at one of California's leading cannabis companiesAfter becoming the first billionaire rapper in June, Jay-Z has been named chief strategist at one of California's leading cannabis companies, Caliva
Source: BusinessInsider - 🏆 729. / 51 Read more »
Jay-Z just partnered with cannabis company Caliva, Caliva CEO discussesWhat will Jay-Z bring to the weed industry? Caliva's CEO discusses the cannabis company's partnership with one of the biggest celebrity names.
Source: CNBC - 🏆 12. / 72 Read more »
Cannabis stocks rally after FDA says it will speed up effort to create rules for CBDCannabis stocks were mostly higher on Monday, after the U.S. Food and Drug Administration said it is expediting its effort to create a regulatory framework... Interesting to watch. How much of this is a hype? Is everything already priced in and the current rally is purely based on the future/speculation?
Source: MarketWatch - 🏆 3. / 97 Read more »